NOOPEPT - PREPARATION WITH NOOTROPIC AND NEUROPROTECTIVE EFFECT

Original formula with triple action. It is an original preparation with a complex effect to improve brain function.
Release form: 50 tablets 10 mg.
Preparation is not a traditional medicine.

Base price: 32,00 €

32,00 €

Discount:

Ask a question about this product

Description

NOOPEPT - PREPARATION WITH NOOTROPIC AND NEUROPROTECTIVE EFFECT is an innovative nootropic product designed to support and enhance brain performance. A treatment course may help reduce symptoms such as forgetfulness, poor concentration, fatigue, and irritability. The nootropic activity of the product is linked to the formation of cycloprolylglycine, structurally related to an endogenous cyclic dipeptide with anti-amnesic properties, along with its cholinergic-supportive action.

Benefits:

Helps prevent memory loss
Supports learning capacity
Promotes better focus and concentration
Assists in memory recovery
May help reduce headaches, orthostatic symptoms, and rapid heartbeat

How it works:

Neurons form the biological foundation of cognitive performance. The healthier the nerve cells and the stronger their interconnections, the more efficiently the brain can process information, solve problems, retain memories, and maintain attention.
Neural cells may be negatively affected by many factors, including trauma, neurological disorders, previous illnesses, aging, chronic stress, and oxygen deficiency.

Noopept® targets cognitive decline through a комплексive mechanism aimed at addressing its root causes.

Noopept® demonstrates both nootropic and neuroprotective activity. It supports learning and memory across all processing stages: encoding, consolidation, and recall. It may help prevent experimentally induced amnesia related to electroshock exposure, cholinergic blockade, glutamatergic dysfunction, and sleep deprivation. The neuroprotective properties of Noopept® increase the resistance of brain tissue to harmful influences such as trauma, hypoxia, toxic exposure, and electroconvulsive damage. The formula has been shown to reduce neuronal injury and support cell survival in laboratory models involving ischemia, glutamate toxicity, and oxidative stress. In addition, Noopept® exhibits antioxidant properties, modulates calcium channel activity, and may improve blood microcirculation through antiplatelet, fibrinolytic, and anticoagulant effects. Its cognitive-supportive effects are associated with cycloprolylglycine formation and positive cholinergic modulation.
Noopept® may enhance communication between the brain hemispheres by increasing transcallosal response amplitude. It also supports restoration of memory and other cognitive functions impaired by traumatic brain injury, ischemia, or prenatal damage caused by hypoxia or alcohol exposure.
Clinical effects in patients with organic CNS disorders may become noticeable within 5–7 days of treatment. Early effects include mild stimulation and anxiolytic action, helping reduce anxiety, irritability, emotional instability, and sleep disturbances. After 14–20 days, improvements in cognition, attention, and memory may become more apparent.
Noopept® also contributes to autonomic nervous system balance and may help alleviate headaches, orthostatic disturbances, and tachycardia.
No withdrawal effects have been observed after discontinuation.
The preparation does not demonstrate toxic effects on internal organs and does not negatively affect blood or urine biochemical parameters. It is considered non-immunotoxic, non-teratogenic, and non-mutagenic.

SUPPORTS NEURONAL FUNCTION

Helps prevent amnesia development
Supports attention and memory retention
Positively influences all memory stages

PROTECTS NERVE CELLS

Enhances brain tissue resilience
Helps prevent neuronal damage
Reduces severity of nerve cell injury

SUPPORTS NEURONAL NUTRITION

Promotes neuronal metabolism
Supports healthy microcirculation

Clinical study findings:

58% of participants reported reduced absent-mindedness after using Noopept®.
77% noted improvement in memory-related complaints after taking Noopept®.
50% experienced reduced fatigue symptoms after use.
90% reported improved mood according to clinical study results.

Recommended dosage:

Take twice daily after meals: 1 tablet in the morning and 1 tablet in the afternoon (before 6:00 PM).
Recommended treatment duration: 1.5–3 months.
The therapeutic effect may become noticeable within 5–7 days.
No withdrawal symptoms are typically observed after stopping use.

Noopept® is intended for oral use after meals. Treatment usually starts with 20 mg daily, divided into two 10 mg doses (morning and afternoon). If additional effect is required and tolerance is good, the dosage may be increased to 30 mg daily, divided into three 10 mg doses. Avoid taking the product after 6 p.m. Recommended treatment duration is 1.5–3 months.

Indications:

Memory impairment, reduced attention, cognitive decline, and emotional instability (including in older adults) associated with:

traumatic brain injury consequences
post-concussion syndrome
cerebrovascular insufficiency and encephalopathy
asthenic conditions
other conditions involving reduced intellectual performance

Contraindications:

Hypersensitivity to any component of the product. Pregnancy and breastfeeding. Individuals under 18 years of age. Severe liver or kidney impairment. Use during pregnancy is contraindicated. If use during lactation is necessary, breastfeeding should be discontinued.

Expected effects:

What may be observed while taking Noopept®:

Days 5–7: Reduced irritability and emotional instability, improved sleep quality.
Days 14–20: Enhanced cognitive performance, memory, and attention.
Recommended course duration: 1.5–3 months.
If necessary, treatment may be repeated after a 1-month interval.

Key features of Noopept®:

Original triple-action formula.
The only "Omberacetam" product available in the Russian Federation.
Supports symptoms associated with mild to moderate cognitive decline.
Acts on all stages of memory processing: encoding, storage, and retrieval.
Does not impair the ability to drive.
Demonstrates a high safety profile.
No known interactions with alcohol, sedatives, antihypertensives, or psychostimulants.

Composition:

Active ingredient: Omberacetam — 10.0 mg

Other ingredients: Lactose monohydrate — 55.0 mg, potato starch — 13.5 mg, microcrystalline cellulose — 10.1–21.2 mg, magnesium stearate — 0.3 mg, povidone (polyvinylpyrrolidone K-25) — 0.0008 mg

Storage:

Store at temperatures below 25°C.
Keep out of reach of children.

Shelf life:

3 years. Do not use after the expiration date shown on the package.

Packaging:

50 tablets, 10 mg each. Supplied in blister packs containing 25 tablets made of PVC film and lacquered aluminum foil. Two blister packs with instructions are packed in a cardboard box.

authentic stamp